Aleks Engel, a Novo partner and Repair Impact Fund director, will work with the firm’s bioindustrial team to accelerate sustainability.

Aleks Engel has joined the bioindustrials division of Novo Holdings, an investment arm of Denmark-based pharmaceutical conglomerate Novo Nordisk. Aleks Engel Engel’s stint at Novo Holdings began in 2014 when he joined as a director of principal investments. He was promoted to partner at the corporate’s life science investment group, Novo Seeds, four years later.…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.